Skip to main content Accessibility help
×
Home

Protein pathways working in human follicular fluid: the future for tailored IVF?

  • Laura Bianchi (a1), Assunta Gagliardi (a1), Claudia Landi (a1), Riccardo Focarelli (a2), Vincenzo De Leo (a3), Alice Luddi (a3), Luca Bini (a1) and Paola Piomboni (a3)...

Abstract

The human follicular fluid (HFF) contains molecules and proteins that may affect follicle growth, oocyte maturation and competence acquiring. Despite the numerous studies, an integrated broad overview on biomolecular and patho/physiological processes that are proved or supposed to take place in HFF during folliculogenesis and oocyte development is still missing. In this review we report, for the first time, all the proteins unambiguously detected in HFF and, applying DAVID (Database for Annotation, Visualization and Integrated Discovery) and MetaCore bioinformatic resources, we shed new lights on their functional correlation, delineating protein patterns and pathways with reasonable potentialities for oocyte quality estimation in in vitro fertilisation (IVF) programs. Performing a rigorous PubMed search, we redacted a list of 617 unique proteins unambiguously-annotated as HFF components. Their functional processing suggested the occurrence in HFF of a tight and highly dynamic functional-network, which is balanced by specific effectors, primarily involved in extracellular matrix degradation and remodelling, inflammation and coagulation. Metalloproteinases, thrombin and vitamin-D-receptor/retinoid-X-receptor-alpha resulted as the main key factors in the nets and their differential activity may be indicative of ovarian health and oocyte quality. Despite future accurate clinical investigations are absolutely needed, the present analysis may provide a starting point for more accurate oocyte quality estimation and for defining personalised therapies in reproductive medicine.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Protein pathways working in human follicular fluid: the future for tailored IVF?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Protein pathways working in human follicular fluid: the future for tailored IVF?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Protein pathways working in human follicular fluid: the future for tailored IVF?
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author: Paola Piomboni, Department of Molecular and Developmental Medicine, University of Siena, Viale Bracci 14, 53100 Siena, Italy. E-mail: piomboni@unisi.it

References

Hide All
1. Stoop, D. et al. (2012) Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles. Human Reproduction 27, 2030-2035
2. Krisher, R.L. (2004) The effect of oocyte quality on development. Journal of Animal Science 82, 14-23
3. Asimakopoulos, B. et al. (2005) Follicular fluid levels of vascular endothelial growth factor and leptin are associated with pregnancy outcome of normal women participating in intracytoplasmic sperm injection cycles. Physiological Research 54, 263-270
4. Kim, Y. et al. (2006) Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 6, 3445-3454
5. Kushnir, M.M. et al. (2012) Protein and steroid profiles in follicular fluid after ovarian hyperstimulation as potential biomarkers of IVF outcome. Journal of Proteome Research 11, 5090-5100
6. Wu, Y.T. et al. (2012) Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders. Reproductive Biology and Endocrinology 10, 116
7. Urieli-Shoval, S. et al. (2013) Serum amyloid a: expression throughout human ovarian folliculogenesis and levels in follicular fluid of women undergoing controlled ovarian stimulation. Journal of Clinical Endocrinology and Metabolism 98, 4970-4978
8. Severino, V. et al. (2013) An integrated approach based on multiplexed protein array and iTRAQ labeling for in-depth identification of pathways associated to IVF outcome. PLoS ONE 8, e77303
9. Angelucci, S. et al. (2006) Proteome analysis of human follicular fluid. Biochimica and Biophysica Acta 1764, 1775-1785
10. Kim, J.A. et al. (2013) The chromenesargachromanol E inhibits ultraviolet A induced ageing of skin in human dermal fibroblasts. British Journal of Dermatology 168, 968-976
11. Anahory, T. et al. (2002) Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis 23, 1197-1202
12. Lee, D.M. et al. (2005) The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilisation pregnancy. BJOG 112, 946-951
13. Ambekar, A.S. et al. (2013) Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis. Journal of Proteomics 87, 68-77
14. Twigt, J. et al. (2012) Proteomic analysis of the microenvironment of developing oocytes. Proteomics 12, 1463-1471
15. Hanrieder, J. et al. (2008) Proteomic analysis of human follicular fluid using an alternative bottom-up approach. Journal of Proteome Research 7, 443-449
16. Jarkovska, K. et al. (2011) Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization. Molecular Human Reproduction 17, 679-692
17. Bianchi, L. et al. (2003) A methodological and functional proteomic approach of human follicular fluid en route for oocyte quality evaluation. Journal of Proteomics 90, 61-76
18. Field, S.L. et al. (2014) Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation. Molecular Reproduction and Development 81, 284-314
19. Cataldi, T. et al. (2013) Lipid profiling of follicular fluid from women undergoing IVF: young poor ovarian responders versus normal responders. Human Fertility (Camb) 16, 269-277
20. Valckx, S.D. et al. (2014) Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study. Reproductive Biology and Endocrinology 12, 13
21. Esmon, C.T. (2005) The interactions between inflammation and coagulation. British Journal of Haematology 131, 417-430
22. Andersen, C.Y. (2002) Possible new mechanism of cortisol action in female reproductive organs: physiological implications of the free hormone hypothesis. Journal of Endocrinology 173, 211-217
23. Wissing, M.L. et al. (2014) Identification of new ovulation-related genes in humans by comparing the transcriptome of granulosa cells before and after ovulation triggering in the same controlled ovarian stimulation cycle. Human Reproduction 29, 997-1010
24. Nissinen, L. and Kähäri, V.M. (2014) Matrix metalloproteinases in inflammation. Biochimica and Biophysica Acta 1840, 2571-2580
25. Shamamian, P. et al. (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. Journal of Cell Physiology 189, 197-206
26. Jackson, P.L. et al. (2010) Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Molecular Medicine 16, 159-166
27. Koo, B.H. et al. (2012) Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation. Journal of Biological Chemistry 287, 22643-22653
28. Okamoto, T. et al. (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. Journal of Biological Chemistry 276, 29596-29602
29. Smith, M.F. et al. (2002) Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Molecular and Cellular Endocrinology 191, 45-56
30. Curry, T.E. Jr and Osteen, K.G. (2003) The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrinological Review 24, 428-465
31. Liu, Y.X. (2004) Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Frontiers in Biosciences 9, 3356-3373
32. Liu, Y.X. et al. (2013) Serine protease and ovarian paracrine factors in regulation of ovulation. Frontiers in Biosciences 18, 650-664
33. Ebisch, I.M. et al. (2007) Possible role of the plasminogen activation system in human subfertility. Fertility and Sterility 87, 619-626
34. Curry, T.E. Jr and Osteen, K.G. (2001) Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biology of Reproduction 64, 1285-1296
35. Peluffo, M.C. et al. (2011) Systematic analysis of protease gene expression in the rhesus macaque ovulatory follicle: metalloproteinase involvement in follicle rupture. Endocrinology 152, 3963-3974
36. Goldman, S. and Shalev, E. (2004) MMPS and TIMPS in ovarian physiology and pathophysiology. Frontiers in Biosciences 9, 2474-2483
37. Fan, D. et al. (2014) Matrix as an interstitial transport system. Circulation Research 114, 889-902
38. Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research 92, 827-839
39. Nagase, H. et al. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 69, 562-573
40. Taipale, J. and Keski-Oja, J. (1997) Growth factors in the extracellular matrix. FASEB Journal 11, 51-59
41. Armstrong, D.G. and Webb, R. (1997) Ovarian follicular dominance: the role of intraovarian growth factors and novel proteins. Review of Reproduction 2, 139-146
42. Sánchez, F. and Smitz, J. (2012) Molecular control of oogenesis. Biochimica and Biophysica Acta 1822, 1896-1912
43. Baker, A.H., Edwards, D.R. and Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Sciences 115, 3719-3727
44. Brew, K. and Nagase, H. (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica and Biophysica Acta 1803, 55-71
45. Shores, E.M. and Hunter, M.G. (2000) Production of tissue inhibitors of metalloproteinases (TIMPs) by pig ovarian cells in vivo and the effect of TIMP-1 on steroidogenesis in vitro. Journal of Reproduction and Fertility 120, 73-81
46. Zhang, B., Moses, M.A. and Tsang, P.C. (2003) Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum. Reprodutive Biology and Endocrinology 1, 85
47. Fedorcsák, P. et al. (2010) Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes. Endocrinology 151, 1290-1298
48. Donnini, S. et al. (2008) Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4. FEBS Letters 582, 1135-1140
49. Agarwal, A. et al. (2012) The effects of oxidative stress on female reproduction: a review. Reproductive Biology and Endocrinology 10, 49
50. Anteby, E.Y. et al. (1996) Human follicular nitric oxide pathway: relationship to follicular size, oestradiol concentrations and ovarian blood flow. Human Reproduction 11, 1947-1951
51. Rosselli, M., Keller, P.J. and Dubey, R.K. (1998) Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Human Reproduction Update 4, 3-24
52. Pasqualotto, E.B. et al. (2004) Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertility and Sterility 81, 973-976
53. Appasamy, M. et al. (2008) Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation. Fertility and Sterility 89, 912-921
54. Tamura, H. et al. (2008) Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. Journal of Pineal Research 44, 280-287
55. Valko, M. et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cellular Biology 39, 44-84
56. Polte, T. and Tyrrell, R.M. (2004) Involvement of lipid peroxidation and organic peroxides in UVA-induced matrix metalloproteinase-1 expression. Free Radical Biology and Medicine 36, 1566-1574
57. Jacob-Ferreira, A.L. and Schulz, R. (2013) Activation of intracellular matrix metalloproteinase-1109 2 by reactive oxygen-nitrogen species: consequences and therapeutic strategies in the heart. Archives in Biochemistry and Biophysics 540, 82-93
58. Soslau, G. et al. (2014) Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin. Thrombosis and Homeostasis 111, 140-153
59. Das, S. et al. (2006) Reactive oxygen species level in follicular fluid – embryo quality marker in IVF? Human Reproduction 21, 2403-2407
60. Chattopadhayay, R. et al. (2010) Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecologic and Obstetrics Investigation 69, 197-202
61. Jana, S.K. et al. (2010) Upper control limit of reactive oxygen species in follicular fluid beyond which viable embryo formation is not favorable. Reproductive Toxicology 29, 447-451
62. Lane, M.A. and Bailey, S.J. (2005) Role of retinoid signalling in the adult brain. Progress in Neurobiology 75, 275-293
63. Chen, D. and Dorling, A. (2009) Critical roles for thrombin in acute and chronic inflammation. Journal of Thrombosis and Haemostasis 7, 122-126
64. Amara, U. et al. (2010) Molecular intercommunication between the complement and coagulation systems. Journal of Immunology 185, 5628-5636
65. Duhamel-Clérin, E. et al. (1997) Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17, 1931-1938
66. Galis, Z.S. et al. (1997) Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17, 483-489
67. Orbe, J. et al. (2009) Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation. Arteriosclerosis, Thrombosis, and Vascular Biology 29, 2109-2116
68. Huang, C.Y. et al. (2013) Thrombin promotes matrix metalloproteinase-13 expression through the PKCδ c-Src/EGFR/PI3K/Akt/AP-1 signaling pathway in human chondrocytes. Mediators of Inflammation 2013, 326041
69. Hotary, K.B. et al. (2002) Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP dependent and -independent processes. Journal of Experimental Medicine 195, 295-308
70. Green, K.A. et al. (2008) Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. Journal of Investigative Dermatology 128, 2092-2101
71. Schrör, K. et al. (2010) Thrombin receptors in vascular smooth muscle cells – function and regulation by vasodilatory prostaglandins. Thrombosis and Haemostasis 103, 884-890
72. Kutteh, W.H. and Triplett, D.A. (2006) Thrombophilias and recurrent pregnancy loss. Seminars in Reproductive Medicine 24, 54-66
73. Hirota, Y. et al. (2003) Possible roles of thrombin-induced activation of protease-activated receptor 1 in human luteinized granulosa cells. Journal of Clinical Endocrinology and Metabolism 88, 3952-3957
74. Osuga, Y., Hirota, Y. and Taketani, Y. (2008) Basic and translational research on proteinase-activated receptors: proteinase-activated receptors in female reproductive tissues and endometriosis. Journal of Pharmacological Sciences 108, 422-425
75. Cheng, Y. et al. (2012) Intraovarian thrombin and activated protein C signaling system regulates steroidogenesis during the periovulatory period. Molecular Endocrinology 26, 331-340
76. Strande, J.L. and Phillips, S.A. (2009) Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro. Journal of Inflammation (Lond) 6, 4
77. O'Brien, M. (2012) The reciprocal relationship between inflammation and coagulation. Topics in Companion Animal Medicine 27, 46-52
78. Lee, K.S. et al. (2000) Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. Journal of Assisted Reproduction and Genetics 17, 222-228
79. Jackson, L.R., Farin, C.E. and Whisnant, S. (2012) Tumor necrosis factor alpha inhibits in vitro bovine embryo development through a prostaglandin mediated mechanism. Journal of Animal Science and Biotechnology 3, 7
80. Naz, R.K., Zhu, X. and Menge, A.C. (1997) Expression of tumor necrosis factor-alpha and its receptors type I and type II in human oocytes. Molecular Reproduction and Development 47, 127-133
81. Hussein, M.R. (2005) Apoptosis in the ovary: molecular mechanisms. Human Reproduction Update 11, 162-177
82. Lirk, P., Hoffmann, G. and Rieder, J. (2002) Inducible nitric oxide synthase – time for reappraisal. Current Drug Targets – Inflammation & Allergy 1, 89-108
83. Obermajer, N. et al. (2013) Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. Journal of Experimental Medicine 210, 1433-1445
84. Vignini, A. et al. (2008) Follicular fluid nitric oxide (NO) concentrations in stimulated cycles: the relationship to embryo grading. Archives of Gynecology and Obstetrics 277, 229-232
85. Kothari, P. et al. (2014) IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. Journal of Immunology 192, 349-357
86. Gearing, A.J. et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555-557
87. Alroy, I., Towers, T.L. and Freedman, L.P. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Molecular and Cell Biology 15, 5789-5799
88. Alvarez-Díaz, S. et al. (2010) Vitamin D: proteases, protease inhibitors and cancer. Cell Cycle 9, 32-37
89. van Greevenbroek, M.M. et al. (2014) Complement c3 is inversely associated with habitual intake of provitamin A but not with dietary fat, fatty acids, or vitamin E in middle-aged to older white adults and positively associated with intake of retinol in middle-aged to older white women. Journal of Nutrition 144, 61-67
90. Jablonski, K.L. et al. (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57, 63-69
91. Hakim, I. and Bar-Shavit, Z. (2003) Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element. Journal of Cell Biochemistry 88, 986-998
92. Zile, M.H. (2001) Function of vitamin A in vertebrate embryonic development. Journal of Nutrition 131, 705-708
93. Cetin, I., Berti, C. and Calabrese, S. (2010) Role of micronutrients in the periconceptional period. Human Reproduction Update 16, 80-95
94. Pauli, S.A. et al. (2013) Analysis of follicular fluid retinoids in women undergoing in vitro fertilization: retinoic acid influences embryo quality and is reduced in women with endometriosis. Reproductive Sciences 20, 1116-1124
95. Rudick, B.J. et al. (2014) Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertility and Sterility 101, 447-452
96. Sugden, M.C. and Holness, M.J. (2008) Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochemical Society Transaction 36, 891-900
97. Nakamura, M.T., Yudell, B.E. and Loor, J.J. (2014) Regulation of energy metabolism by long-chain fatty acids. Progress in Lipid Research 53, 124-144
98. Ramagopalan, S.V. et al. (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research 20, 1352-1360
99. Hossein-nezhad, A., Spira, A. and Holick, M.F. (2013) Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS ONE 8, e58725
100. Lerchbaum, E. and Obermayer-Pietsch, B. (2012) Vitamin D and fertility: a systematic review. European Journal of Endocrinology 166, 765-778
101. Wang, Y., Zhu, J. and De Luca, H.F. (2012) Where is the vitamin D receptor? Archives of Biochemistry and Biophysics 523, 123-133
102. Irani, M. et al. (2014) Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. Journal of Clinical Endocrinology and Metabolism 99, E886-E890
103. Fujii, E.Y. and Nakayama, M. (2010) The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertility and Sterility 94, 694-700
104. Malicková, K. et al. (2010) Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles – a preliminary study. Clinical Laboratory 56, 377-384
105. Bonetti, T.C. et al. (2013) Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction. Reproductive Biomedicine Online 26, 62-67
106. Hudson, B.I. et al. (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB Journal 22, 1572-1580
107. Tatone, C. et al. (2008) Cellular and molecular aspects of ovarian follicle ageing. Human Reproduction Update 14, 131-142
108. Yan, C. and Boyd, D.D. (2007) Regulation of matrix metalloproteinase gene expression. Journal of Cell Physiology 211, 19-26
109. Diamanti-Kandarakis, E. et al. (2008) Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clinical Endocrinology (Oxf) 69, 634-641
110. Kellow, N.J. and Savige, G.S. (2013) Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. European Journal of Clinical Nutrition 67, 239-248
111. Vlassara, H. and Uribarri, J. (2014) Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Current Diabetes Reports 14, 453
112. Singh, V.P. et al. (2014) Advanced glycation end products and diabetic complications. Korean Journal of Physiology and Pharmacology 18, 1-14
113. Diamanti-Kandarakis, E. et al. (2007) Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochemistry and Cell Biology 127, 581-589
114. Merhi, Z. (2014) Advanced glycation end products and their relevance in female reproduction. Human Reproduction 29, 135-145
115. Jinno, M. et al. (2011) Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Human Reproduction 26, 604-610
Type Description Title
WORD
Supplementary materials

Bianchi supplementary material S1
Bianchi supplementary material

 Word (98 KB)
98 KB
WORD
Supplementary materials

Bianchi supplementary material S2
Bianchi supplementary material

 Word (85 KB)
85 KB
WORD
Supplementary materials

Bianchi supplementary material S3
Bianchi supplementary material

 Word (378 KB)
378 KB
WORD
Supplementary materials

Bianchi supplementary material S4
Bianchi supplementary material

 Word (111 KB)
111 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed